Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emuella Flood

Showing results (31-40 of 49) with videos related to

Pageof 5
Sort By:
Cancer Investigation|November 17, 2025
Patient-Centered Real-World Evidence Framework for Oncology Product DevelopmentNenad Medic, Dina Filipenko, Monica Hadi, et al.
Therapeutic Innovation & Regulatory Science|March 9, 2026
Incorporating Patient Perspectives into Structured Benefit-Risk Assessment: A Drug Development Framework RecommendationEmuella Flood, Niklas Karlsson, Jennifer Ostridge, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 4, 2017
Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference StudyLei Qin, Stephanie Chen, Emuella Flood, et al.
Future Oncology (London, England)|June 16, 2025
Patient preferences for treatment pathways in early-stage breast cancer: application of a discrete choice experimentChristian Jackisch, Chikako Shimizu, Emuella Flood, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 26, 2017
Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United KingdomLei Qin, Stephanie Chen, Emuella Flood, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 10, 2019
The evolving role of patient preference studies in health-care decision-making, from clinical drug development to clinical care managementYanina Jackson, Ellen Janssen, Ryan Fischer, et al.
Clinical Genitourinary Cancer|September 30, 2014
Health-related quality of life in advanced prostate cancer and its treatments: biochemical failure and metastatic disease populationsOliver Sartor, Emuella Flood, Kathleen Beusterien, et al.
Future Oncology (London, England)|October 18, 2019
Patient preferences for attributes of tyrosine kinase inhibitor treatments for EGFR mutation-positive non-small-cell lung cancerJohn Fp Bridges, Marie de la Cruz, Melissa Pavilack, et al.
The Patient|October 26, 2014
Unmet needs associated with attention-deficit/hyperactivity disorder in eight European countries as reported by caregivers and adolescents: results from qualitative researchVanja Sikirica, Emuella Flood, C Noelle Dietrich, et al.
Plos One|January 17, 2023
Using qualitative interviews to identify patient-reported clinical trial endpoints and analyses that are the most meaningful to patients with advanced breast cancerEmuella Flood, Anna Krasnow, Cecilia Orbegoso, et al.
Pageof 5

Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Cancer Investigation|November 17, 2025
Patient-Centered Real-World Evidence Framework for Oncology Product DevelopmentNenad Medic, Dina Filipenko, Monica Hadi, et al.
Therapeutic Innovation & Regulatory Science|March 9, 2026
Incorporating Patient Perspectives into Structured Benefit-Risk Assessment: A Drug Development Framework RecommendationEmuella Flood, Niklas Karlsson, Jennifer Ostridge, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 4, 2017
Glucagon-like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Naïve Patients with Type 2 Diabetes Mellitus: A Multinational Preference StudyLei Qin, Stephanie Chen, Emuella Flood, et al.
Future Oncology (London, England)|June 16, 2025
Patient preferences for treatment pathways in early-stage breast cancer: application of a discrete choice experimentChristian Jackisch, Chikako Shimizu, Emuella Flood, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|February 26, 2017
Glucagon-Like Peptide-1 Receptor Agonist Treatment Attributes Important to Injection-Experienced Patients with Type 2 Diabetes Mellitus: A Preference Study in Germany and the United KingdomLei Qin, Stephanie Chen, Emuella Flood, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|May 10, 2019
The evolving role of patient preference studies in health-care decision-making, from clinical drug development to clinical care managementYanina Jackson, Ellen Janssen, Ryan Fischer, et al.
Clinical Genitourinary Cancer|September 30, 2014
Health-related quality of life in advanced prostate cancer and its treatments: biochemical failure and metastatic disease populationsOliver Sartor, Emuella Flood, Kathleen Beusterien, et al.
Future Oncology (London, England)|October 18, 2019
Patient preferences for attributes of tyrosine kinase inhibitor treatments for EGFR mutation-positive non-small-cell lung cancerJohn Fp Bridges, Marie de la Cruz, Melissa Pavilack, et al.
The Patient|October 26, 2014
Unmet needs associated with attention-deficit/hyperactivity disorder in eight European countries as reported by caregivers and adolescents: results from qualitative researchVanja Sikirica, Emuella Flood, C Noelle Dietrich, et al.
Plos One|January 17, 2023
Using qualitative interviews to identify patient-reported clinical trial endpoints and analyses that are the most meaningful to patients with advanced breast cancerEmuella Flood, Anna Krasnow, Cecilia Orbegoso, et al.
Pageof 5